Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXUW0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,275
Award facts
- Contract value 100% obligated
- $51,275.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $51,275.40 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on January 22, 2026, with an ultimate completion date of February 12, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction within the federal pharmaceutical procurement process. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical supply needs.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999.99 billion vehicle valued through December 2031 that enables the supply of pharmaceutical products and medical supplies to support military healthcare programs globally. The underlying IDC encompasses a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in delivering essential pharmaceutical products to military treatment facilities and other federal healthcare systems through both full and open competition.
Quick answers
Who was awarded contract SPE2DR26FXUW0?
SPE2DR26FXUW0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FXUW0 worth?
The government has obligated $51,275 on SPE2DR26FXUW0.
Is contract SPE2DR26FXUW0 an order under another contract?
Yes. SPE2DR26FXUW0 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUW0 competed?
The extent of competition for SPE2DR26FXUW0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award